News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GlycoMimetics, Inc. (GLYC) Announces Sudden Passing Of Board Director And Audit Committee Member William Gust


3/14/2014 7:24:52 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

GlycoMimetics, Inc. (NASDAQ: GLYC) reported today with great sorrow the sudden passing of William “Bill” Gust, who had served as a director of the company since 2006 and as a member of the audit committee of the Company’s board of directors.

“Bill was one of the first investors in GlycoMimetics. We greatly appreciate his early support of the Company, as well as the advice and counsel provided to us over the years that he served on our Board. We will miss him,” said Rachel King, Chief Executive Officer of GlycoMimetics.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES